Preprint · OA via OpenAlex

Pharmacological inhibition of LSD1 and mTOR reduces mitochondrial retention and associated ROS levels in the red blood cells of sickle cell disease

Ramasamy Jagadeeswaran, Benjamin Vazquez, Muthusamy Thiruppathi, Balaji Ganesh, Vinzon Ibañez, Shuaiying Cui, James Douglas Engel, Alan M. Diamond, Robert E. Molokie, Joseph DeSimone, Donald Lavelle, Angela Rivers

Experimental Hematology · 2017 · ▲ 90 citations

Deregulated nutrient-sensing Mitochondrial dysfunction

＋ Sign in to save

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: OpenAlex
DOI: 10.1016/j.exphem.2017.02.003
Canonical: link ↗
Fetched: 2026-06-13 MST

Cite this

APA

Jagadeeswaran, R., Vazquez, B., Thiruppathi, M., Ganesh, B., Ibañez, V., Cui, S., Engel, J.D., Diamond, A.M., Molokie, R.E., DeSimone, J., Lavelle, D., & Rivers, A. (2017). Pharmacological inhibition of LSD1 and mTOR reduces mitochondrial retention and associated ROS levels in the red blood cells of sickle cell disease. <em>Experimental Hematology</em>. https://doi.org/10.1016/j.exphem.2017.02.003

Vancouver

Jagadeeswaran R, Vazquez B, Thiruppathi M, Ganesh B, Ibañez V, Cui S, et al. Pharmacological inhibition of LSD1 and mTOR reduces mitochondrial retention and associated ROS levels in the red blood cells of sickle cell disease. Experimental Hematology. 2017. doi:10.1016/j.exphem.2017.02.003.

BibTeX

@unpublished{ramasamy2017Pharma, title = {Pharmacological inhibition of LSD1 and mTOR reduces mitochondrial retention and associated ROS levels in the red blood cells of sickle cell disease}, author = {Ramasamy Jagadeeswaran and Benjamin Vazquez and Muthusamy Thiruppathi and Balaji Ganesh and Vinzon Ibañez and Shuaiying Cui and James Douglas Engel and Alan M. Diamond and Robert E. Molokie and Joseph DeSimone and Donald Lavelle and Angela Rivers}, journal = {Experimental Hematology}, year = {2017}, doi = {10.1016/j.exphem.2017.02.003}, }